Baxter International | BAX - الربح قبل الضريبة

سعر السهم
17.17
التغيير اليومي
-0.77 -4.29%
شهريا
8.67%
سنويا
-44.92%
Q2 التوقعات
17.77




الربح قبل الضريبة تغيير تاريخ
Abbott USD 2.39B 27M 2026-03
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Fresenius EUR 601M 122M 2025-12
Globus Medical USD 143.99M 44.18M 2025-09
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
ICU Medical USD 70.3M 36.62M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Laboratory Of America USD 337M 32.3M 2025-09
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Quest Diagnostics USD 334M 4M 2026-03
Smith & Nephew USD 469M 70M 2025-12
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12